SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Statistics

Total Valuation

KRX:326030 has a market cap or net worth of KRW 8.67 trillion. The enterprise value is 8.54 trillion.

Market Cap	8.67T
Enterprise Value	8.54T

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:326030 has 78.31 million shares outstanding.

Current Share Class	78.31M
Shares Outstanding	78.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	12.44%
Float	28.07M

Valuation Ratios

The trailing PE ratio is 33.87 and the forward PE ratio is 44.08. KRX:326030's PEG ratio is 11.30.

PE Ratio	33.87
Forward PE	44.08
PS Ratio	13.98
PB Ratio	14.12
P/TBV Ratio	14.77
P/FCF Ratio	85.84
P/OCF Ratio	83.98
PEG Ratio	11.30

Enterprise Valuation

The stock's EV/EBITDA ratio is 67.22, with an EV/FCF ratio of 84.56.

EV / Earnings	33.36
EV / Sales	13.77
EV / EBITDA	67.22
EV / EBIT	78.11
EV / FCF	84.56

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.12.

Current Ratio	2.19
Quick Ratio	1.54
Debt / Equity	0.12
Debt / EBITDA	0.45
Debt / FCF	0.74
Interest Coverage	14.74

Financial Efficiency

Return on equity (ROE) is 49.08% and return on invested capital (ROIC) is 14.56%.

Return on Equity (ROE)	49.08%
Return on Assets (ROA)	10.38%
Return on Invested Capital (ROIC)	14.56%
Return on Capital Employed (ROCE)	21.40%
Revenue Per Employee	2.52B
Profits Per Employee	1.04B
Employee Count	246
Asset Turnover	0.70
Inventory Turnover	0.36

Taxes

Income Tax	-145.81B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.14% in the last 52 weeks. The beta is 0.89, so KRX:326030's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+6.14%
50-Day Moving Average	101,468.00
200-Day Moving Average	102,891.00
Relative Strength Index (RSI)	68.20
Average Volume (20 Days)	176,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:326030 had revenue of KRW 620.28 billion and earned 255.99 billion in profits. Earnings per share was 3,268.81.

Revenue	620.28B
Gross Profit	577.47B
Operating Income	147.55B
Pretax Income	96.06B
Net Income	255.99B
EBITDA	165.28B
EBIT	147.55B
Earnings Per Share (EPS)	3,268.81

Balance Sheet

The company has 222.60 billion in cash and 74.99 billion in debt, giving a net cash position of 147.61 billion or 1,884.91 per share.

Cash & Cash Equivalents	222.60B
Total Debt	74.99B
Net Cash	147.61B
Net Cash Per Share	1,884.91
Equity (Book Value)	614.07B
Book Value Per Share	7,600.72
Working Capital	312.93B

Cash Flow

In the last 12 months, operating cash flow was 103.23 billion and capital expenditures -2.23 billion, giving a free cash flow of 101.00 billion.

Operating Cash Flow	103.23B
Capital Expenditures	-2.23B
Free Cash Flow	101.00B
FCF Per Share	1,289.65

Margins

Gross margin is 93.10%, with operating and profit margins of 23.79% and 41.27%.

Gross Margin	93.10%
Operating Margin	23.79%
Pretax Margin	15.49%
Profit Margin	41.27%
EBITDA Margin	26.65%
EBIT Margin	23.79%
FCF Margin	16.28%

Dividends & Yields

KRX:326030 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.95%
FCF Yield	1.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:326030 has an Altman Z-Score of 15.02 and a Piotroski F-Score of 6.

Altman Z-Score	15.02
Piotroski F-Score	6